Comparison of captopril with enalapril in the treatment of heart failure: Influence on hemodynamics and measures of renal function

[1]  P. Meredith,et al.  Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man , 2005, Cardiovascular Drugs and Therapy.

[2]  B. Greenberg,et al.  Studies of Left Ventricular Dysfunction (SOLVD). , 1993, The American journal of geriatric cardiology.

[3]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[4]  K. Swedberg.  Effect of ACE-inhibition on renal function in severe congestive heart failure. , 1991, Zeitschrift fur Kardiologie.

[5]  C. Frampton,et al.  Renal Effects of ACE Inhibition in Ovine Heart Failure: A Comparison of Intermittent and Continuous ACE Inhibition , 1990, Journal of cardiovascular pharmacology.

[6]  G. Riegger.  The Effects of ACE Inhibitors on Exercise Capacity in the Treatment of Congestive Heart Failure , 1990, Journal of cardiovascular pharmacology.

[7]  J. Rouleau,et al.  Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure , 1989 .

[8]  G. Francis,et al.  Long-term effects of a once-a-day versus twice-a-day regimen of enalapril for congestive heart failure. , 1989, The American journal of cardiology.

[9]  K. Swedberg,et al.  Enalapril for congestive heart failure. , 1989, The American journal of cardiology.

[10]  H. Ehmke,et al.  Physiology of the renal baroreceptor mechanism of renin release and its role in congestive heart failure. , 1988, The American journal of cardiology.

[11]  M. Wilén,et al.  Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group. , 1988, JAMA.

[12]  D. Ganten,et al.  Tissue Renin-Angiotensin Systems: Focus on the Heart , 1987, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[13]  M. Packer,et al.  Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. , 1987, Annals of internal medicine.

[14]  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1987, The New England journal of medicine.

[15]  A. DeMaria,et al.  A Double‐Blind Comparison of Lisinopril with Captopril in Patients with Symptomatic Congestive Heart Failure , 1987, Journal of cardiovascular pharmacology.

[16]  M. Packer,et al.  Comparison of captopril and enalapril in patients with severe chronic heart failure. , 1986, The New England journal of medicine.

[17]  M. Packer,et al.  Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system. , 1986, Circulation.

[18]  R. Heel,et al.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. , 1986, Drugs.

[19]  J. Cohn,et al.  A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response. , 1985, American heart journal.

[20]  P. Poole‐Wilson,et al.  Measurement of cardiac output during exercise by the thermodilution and direct Fick techniques in patients with chronic congestive heart failure. , 1985, The American journal of cardiology.

[21]  T. Ryan,et al.  Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. , 1985, Journal of the American College of Cardiology.

[22]  M. Wilén,et al.  Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. , 1985, Journal of the American College of Cardiology.

[23]  M. Manning,et al.  The use of antagonists of vasopressin in studies of its physiological functions. , 1985, Federation proceedings.

[24]  B. W. East,et al.  Captopril in heart failure. A double blind controlled trial. , 1984, British heart journal.

[25]  M. Pfeffer,et al.  Role of Angiotensin II in the Altered Renal Function of Congestive Heart Failure , 1984, Circulation research.

[26]  D. Sharpe,et al.  Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. , 1984, Circulation.

[27]  J. Cohn,et al.  Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure. , 1984, Circulation.

[28]  M. Packer,et al.  Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. , 1983, Circulation.

[29]  B. Massie,et al.  Controlled Trial of Captopril in Chronic Heart Failure: A Rest and Exercise Hemodynamic Study , 1983, Circulation.

[30]  J. Biollaz,et al.  Three new long‐acting converting‐enzyme inhibitors: Relationship between plasma converting‐enzyme activity and response to angiotensin I , 1981, Clinical pharmacology and therapeutics.

[31]  T. Lohmeier,et al.  Control of glomerular filtration rate by renin-angiotensin system. , 1977, The American journal of physiology.

[32]  M. da Prada,et al.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. , 1976, Life sciences.

[33]  E. Haber,et al.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. , 1969, The Journal of clinical endocrinology and metabolism.

[34]  Renal clearance , 1962 .